Delivery Order SPE2DB20D3303-SPE2DB25FA2QL
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the topical ointment medication Eucrisa (crisaborole) 2% in 60-gram units. The $3,673.74 firm-fixed-price contract has a completion date of February 15, 2023 and does not include any set-aside requirements, indicating open competition. AmerisourceBergen is the prime contractor for this delivery order, which is a part of the company's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eucrisa 2% ointment. The contract has a ceiling value of $3,364.91 and runs through October 8, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to...
- This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $4,305.06, is for the supply of Eucrisa 2% Ointment 60 GM to DLA facilities in support of the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,777.97 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Eucrisa 2% ointment, a topical medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $4,100 to Amerisourcebergen Drug Corporation to provide 60 grams of EUCRISA 2% ointment. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical product under the contract. The place of performance is listed as Conshohocken, Pennsylvania, and the period of performance is one day, from July 19, 2023 through July 20, 2023. The Defense Logistics Agency is...
- This federal contract award is for the delivery of the pharmaceutical product Eucrisa 2% Ointment 60GM to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies. The contract, valued at $12,554.16, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 17, 2021. It...
- The Defense Logistics Agency Troop Support Medical awarded a $904.12 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 60 grams of EUCRISA 2% ointment. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 25-26, 2023. This delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of the Defense Logistics Agency's medical supply...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,808.20 firm-fixed-price contract is for the supply of EUCRISA 2% ointment, a pharmaceutical product, with an ultimate completion date of August 17, 2023. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award. The company is a major supplier of pharmaceutical products and medical supplies to...
- Amerisourcebergen Drug Corp has received a $3,678.93 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562950604 EUCRISA 2% OINTMENT 60GM. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to meet DLA's requirements by December 1, 2023. The delivery order was awarded without a set-aside designation against an existing indefinite delivery contract held by Amerisourcebergen's Corporate Office...
- The federal contract award is for the delivery of Eucrisa 2% ointment, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,384.68 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2QLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Eucrisa 2% Ointment in 60-gram quantities, with a ceiling value of $1,688.16. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency and other government healthcare systems through this prime contract vehicle. As a leading supplier to military healthcare programs, the company maintains an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for the dermatological treatment Eucrisa exemplifies the company's role in supporting comprehensive pharmaceutical needs within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/15/25 |